Literature DB >> 29850535

A Systematic Review and Meta-Analysis of Epidemiology and Clinical Manifestations of Human Brucellosis in China.

Rongjiong Zheng1, Songsong Xie1, Xiaobo Lu1, Lihua Sun1, Yan Zhou1, Yuexin Zhang1, Kai Wang2.   

Abstract

Background. Brucellosis has a wide spectrum of clinical manifestations and it may last several days or even several years; however, it is often misdiagnosed and therefore may cause inadequate therapy and prolonged illness. Previous studies about meta-analysis of manifestations of brucellosis reported in English lacked the data published in Chinese, which did not provide details about the contact history, laboratory tests, and misdiagnosis. We undertake a meta-analysis of clinical manifestations of human brucellosis in China to identify those gaps in the literature. We have searched published articles in electronic databases up to December 2016 identified as relating to clinical features of human brucellosis in China. 68 studies were included in the analysis. The main clinical manifestations were fever, fatigue, arthralgia, and muscle pain (87%, 63%, 62%, and 56%, resp.). There are significant differences between adults and children. Rash, respiratory and cardiac complications, and orchitis/epididymitis were more prevalent in children patients. The common complications of brucellosis were hepatitis, followed by osteoarthritis, respiratory diseases, cardiovascular diseases, central nervous system dysfunction, hemophagocytic syndrome, and orchitis/epididymitis in male. In the nonpastoral areas, brucellosis has a high ratio of misdiagnosis. Our analysis provides further evidence for the accurate diagnosis, particularly in assessing severe, debilitating sequelae of this infection.

Entities:  

Mesh:

Year:  2018        PMID: 29850535      PMCID: PMC5937618          DOI: 10.1155/2018/5712920

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

Brucellosis is one of the most common zoonotic infections globally [1, 2]. The disease is transmitted to humans by direct/indirect contact with infected animals or through the consumption of raw meat and dairy products [3, 4]. The main transmission routes are digestive tract, skin, and mucosal and respiratory tract contact with blood body fluids and aerosols. Brucellosis has a wide spectrum of clinical manifestations, often lacks specificity, may last from several days to more than a year, is often misdiagnosed, and therefore causes inadequate therapy and prolonged illness can cause a severely debilitating and disabling illness. Patients may show fever, sweating, fatigue, and osteoarthritis [5] and even more serious conditions in different organ systems [6]. Brucellosis not only causes huge economic loss to the society by influencing the production of animal husbandry, but also threatens the human's physical and mental health [7]. Brucellosis was first reported in China in 1905 [8]. In recent years, human brucellosis incidence has increased sharply [9, 10]. Nationwide surveillance data indicated that the total incidence rate of human brucellosis in mainland China increased from 0.92 cases/100,000 people in 2004 to 4.2 cases/100,000 people in 2014 [11-13]. Currently, human brucellosis remains one of major public health issues in China. This study presents a systematic review of scientific literature published before December 2016 identified as relating to clinical features of brucellosis in China. The objectives of this review were to identify those gaps in the literature of epidemiology, clinical manifestations, contact history, laboratory tests, and misdiagnosis of human brucellosis in China and provide further evidence for the accurate diagnosis, particularly in assessing severe, debilitating sequelae of human brucellosis.

2. Methods

2.1. Search Strategy

We performed a systematic review of the literature to identify articles relating to clinical features of human brucellosis in China. With assistance of a professional medical librarian we electronically searched the literature in Wan Fang Data, Wei Pu Data, CNKI, Medline, Cochrane Library, and PubMed with MESH and keyword subject headings “brucellosis,” “malta fever,” “brucella melitensis,” or “brucella abortus,” AND “symptom,” “sequelae,” “morbidity,” “mortality,” “transmission mode,” “foodborne,” and “China,” for entries published from databases' inception before December 2016. We did not restrict the types of studies and publication languages. Duplicate entries were identified by two investigators screening the titles and abstracts of the article, the author, the year of publication, and the volume, issue, and page numbers of the source, and reviewing potentially relevant articles in full.

2.2. Selection Criteria

We systematically and inclusively reviewed articles by two investigators. The reviewers selected articles first by title and abstract, next by full text, and last by analyzing eligible studies in detail until demonstrating 100% agreement in articles included and excluded by two investigators. Studies with the following criteria were excluded: (A) articles related to non-human brucellosis; (B) reported data that overlapped with already included articles; (C) articles that could not provide original data of the patients; (D) articles addressing topics that were not related to the clinical features of human brucellosis, such as treatment intervention and experimental laboratory studies. Studies with the following criteria were included: (A) the literatures that described the clinical symptoms/syndromes of human brucellosis and the number of study subjects must more than 10 in each document; (B) the subjects reported in the literature who must be in China; (C) studies that provided data from general brucellosis cases and presented relevant laboratory results.

2.3. Data Extraction

Data was extracted by two reviewers independently including data collection, study design, study location, patient characteristics, the number of male and female patients, clinical manifestations, numbers of subjects with each symptom and complication which were recorded for each study, methods of diagnosis, and laboratory parameters. For the sex-related outcomes of epididymo/orchitis, the study population was considered to be only the male subgroups of the study population. Children patients must be of the age of 0–15 years. We also recorded the information relating to duration of illness prior to treatment, diagnostic delay, and exposure to potential risk factors. The results of data extraction must reach an agreement and consensus between the reviewers.

2.4. Statistical Analyses

We defined an event rate as the ratio of number of reported cases with a specific clinical manifestation to the total number of reported cases in each study. R statistical software (version 3.4.2, meta package) will be used for creating Forest plots to summarize composite data, generating proportions and corresponding 95% confidence intervals for each manifestation. Two-sided P values < 0.05 will be considered statistically significant during hypothesis testing.

3. Results

3.1. Systematic Review

Literature searches yielded 1991 potential articles, leaving 68 publications that met inclusion and exclusion criteria for data extraction and final analyses. 68 studies represented 12842 patients with human brucellosis in China. The male : female ratio was 2.64 : 1. All 68 articles included in the analysis were case series studies. Figure 1 illustrates the detailed search process.
Figure 1

Procedure of the selection process.

Studies selected from 20 provinces or autonomous regions of China, including 39 studies from pastoral areas (12 from Xinjiang, 9 from Heilongjiang, 7 from Inner Mongolia, 4 from Jilin, 4 from Ningxia, 2 from Gansu, and 1 from Liaoning) and 29 studies from nonpastoral areas (6 from Shandong, 5 from Beijing, 3 from Henan, 3 from Shanxi, 2 from Hebei, 2 from Shaanxi, 2 from Tianjin, 1 from Guangdong, 1 from Hunan, 1 from Jiangsu, 1 from Jiangxi, 1 from Yunnan, and 1 from Zhejiang). The geographic distributions of the numbers of subjects from each selected study are shown in Figure 2.
Figure 2

The geographic distribution of the numbers of subjects from each selected study.

We identified 41 studies which included both children and adult patients [14-54]. 10 studies investigated children with an upper age limit ranging from 0 months to 15 years [55-64]. 17 studies were about the adults who are more than 15 years old [65-81]. The results are presented in detail in Table 1.
Table 1

Main characteristics of all studies included in the meta-analysis.

First author & ref. numberYearAge categoryLocationCasesAvailable contact history dataAvailable laboratory dataAvailable blood culture dataAvailable misdiagnosis data
Wu et al. [14]2012All agesBeijing44YesNANAYes
Dai et al. [15]2013All agesBeijing23YesYesYesNA
Ge et al. [16]2011All agesBeijing66YesYesYesYes
Tong et al. [17]2013All agesBeijing35YesNANANA
Guo and Xu [18]2013All agesBeijing21YesYesYesYes
Wang et al. [19]2015All agesGansu61YesYesNANA
Gao et al. [20]2002All agesGansu182YesNANANA
Zhang et al. [21]2012All agesHenan21YesYesYesNA
Li et al. [22]2016All agesHenan905YesNANANA
Zhou [23]2009All agesHenan241NANANAYes
Li et al. [24]2008All agesHeilongjiang165YesYesYesNA
Liu and Zhang [25]2016All agesInner Mongolia44NANANANA
Liu et al. [26]2015All agesHeilongjiang314NAYesYesNA
Meng et al. [27]2015All agesHeilongjiang3318NANAYesNA
Gong et al. [28]2010All agesHeilongjiang1470NANANANA
Liu et al. [29]2012All agesHeilongjiang229YesYesYesYes
Sun et al. [30]2010All agesJilin270YesNANANA
Wang et al. [31]2014All agesLiaoning88YesNANANA
Xie et al. [32]2016All agesInner Mongolia166NANANANA
Sheng and Ma [33]2009All agesInner Mongolia829NANANANA
Sun et al. [34]2014All agesInner Mongolia126YesYesYesNA
W. Yang and F. Yang [35]2015All agesInner Mongolia228YesYesNAYes
Duan [36]2015All agesNingxia57YesNANANA
Zhang and Wang [37]2013All agesNingxia128YesNANAYes
Wang [38]2005All agesShandong62YesNANANA
Wang and Xiong [39]2011All agesShandong235NAYesNAYes
Lian et al. [40]2015All agesShandong232YesNANAYes
Gao [41]2016All agesShandong94YesNANANA
Wang et al. [42]2014All agesShandong96YesNAYesYes
Wang [43]2010All agesShanxi86YesNANANA
Feng and Deng [44]2016All agesShanxi105YesYesYesYes
An et al. [45]2001All agesShaanxi622YesNANANA
Zhang et al. [46]2016All agesYunnan43YesYesYesNA
Guo et al. [47]2016All agesXinjiang124YesNANANA
Pan et al. [48]2013All agesXinjiang153YesYesNANA
Zhang and Liu [49]2013All agesXinjiang57YesYesYesYes
Yang et al. [50]2015All agesXinjiang125NANANAYes
Zhang [51]2016All agesXinjiang191YesYesNANA
Ju et al. [52]2011All agesXinjiang156YesYesYesNA
Gao et al. [53]2012All agesXinjiang426NANANANA
Wang et al. [54]2015All agesXinjiang117YesYesYesNA
Wang et al. [55]2014ChildrenHebei80YesNANANA
Zeng et al. [56]2014ChildrenJilin23YesYesYesYes
Wang et al. [57]2016ChildrenXinjiang16YesYesNANA
Fan et al. [58]2016ChildrenXinjiang24YesYesNANA
Zhang et al. [59]2006ChildrenJilin25NAYesNANA
Yu et al. [60]2012ChildrenHeilongjiang38NAYesNANA
Lu and Liu [61]2015ChildrenInner Mongolia17YesYesNANA
Liu et al. [62]2016ChildrenHeilongjiang94YesYesYesYes
Bai and Duan [63]2015ChildrenNingxia48YesYesYesYes
He [64]2015ChildrenXinjiang19YesYesYesYes
Zheng et al. [65]2016AdultsGuangdong12YesYesYesNA
Tong et al. [66]2008AdultsHebei25YesYesYesYes
Chen and Dong [67]2016AdultsHeilongjiang60YesNANANA
Huang [68]2016AdultsHunan17YesYesYesYes
Ji et al. [69]2006AdultsHeilongjiang30NAYesYesNA
M. Wang and L. Wang [70]2007AdultsJilin26YesYesNAYes
Zhang et al. [71]2016AdultsJiangsu39YesYesYesYes
Guo et al. [72]2016AdultsJiangxi12YesYesYesYes
Zhang [73]2011AdultsInner Mongolia27YesYesNANA
Yan et al. [74]2016AdultsNingxia31NAYesYesNA
Li et al. [75]2015AdultsShandong21YesYesYesYes
Wu et al. [76]2007AdultsShanxi28YesYesNANA
Zhang and Li [77]2015AdultsShaanxi35YesYesYesNA
Wang [78]2014AdultsTianjin17YesYesYesYes
Zhou and Yang [79]2014AdultsTianjin18YesYesYesNA
Xu et al. [80]2007AdultsZhejiang31YesNANANA
Chen et al. [81]2016AdultsXinjiang74YesYesNANA

3.2. Contact History

54 studies provided data about contact history (see Table 2). Most of the patients (79.4% [95% CI 76.5%–82.4%]) had histories of closely contacting with cattle, sheep, pigs, and dogs. 11.5% (95% CI 8.4%–15.7%) cases had consumption history of uncooked meat or dairy products. 16.7% (95% CI 13.5%–20.8%) cases got the infection of brucellosis with unknown reason. The brucellosis is mostly associated with direct/indirect contact with infected animals or through the consumption of animal products in China.
Table 2

Meta-analysis of the contact history.

Contact n Proportion [95% CI]
Contact history54 0.794 [0.7651; 0.8240]
Digestive tract contact31 0.115 [0.0844; 0.1567]
Unknown43 0.167 [0.1347; 0.2077]

3.3. Clinical Syndromes and Complications

Table 3 shows the clinical syndromes and complications of patients by age category. There are 17 articles specifically describing the clinical characteristics of adult brucellosis representing 503 patients (male 408, female 95). Fever was the most common clinical syndrome (pooled rate 99% [95% CI 97%–100%]), followed by muscle pain (76% [95% CI 60%–95%]), fatigue (64% [95% CI 55%–74%]), arthralgia (61% [95% CI 52%–70%]), and sweating (57% [95% CI 48%–68%]). 10 articles specifically describe the clinical characteristics of children brucellosis including 384 patients (male 249, female 135). The most common symptoms of children patients were fever (92% [95% CI 87%–97%]), fatigue (68% [95% CI 56%–83%]), sweating (60% [95% CI 45%–79%]), and arthralgia (52% [95% CI 43%–64%]). The remaining 41 articles include pediatric and adult patients, a total of 11955 cases (male 8654, female 3301). Children patients have a higher incidence rate of rash, respiratory and cardiac complications, and orchitis/epididymitis. The morbidity of chills, headache, and weight loss are lower compared to adults.
Table 3

Meta-analysis of clinical manifestations of brucellosis by age category.

ManifestationAge categoryAll studies
ChildrenAdultsAll ages
General n % [95% CI] n % [95% CI] n % [95% CI] n % [95% CI]
Fever1092 [87; 97]1799 [97; 100]4183 [80; 87]6887 [85; 90]
Fatigue768 [56; 83]1464 [55; 74]3462 [57; 67]5563 [59; 67]
Chills326 [8; 82]553 [36; 79]437 [33; 42]1243 [33; 55]
Sweats860 [45; 79]1657 [48; 68]3954 [49; 59]6355 [51; 60]
Arthralgia952 [43; 64]1761 [52; 70]4063 [59; 68]6662 [58; 65]
Headache48 [3; 19]1029 [19; 42]2721 [18; 25]4121 [18; 25]
Muscle pain231 [7; 100]576 [60; 95]2053 [47; 59]2756 [51; 62]
Nausea/vomiting627 [16; 43]826 [15; 45]1725 [19; 34]3126 [21; 33]
Rash313 [6; 29]37 [3; 19]95 [3; 11]157 [4; 11]
Weight loss0-426 [14; 47]532 [17; 61]929 [17; 48]
Skin petechia38 [4; 18]218 [10; 32]95 [3; 8]147 [4; 10]
Abdominal pain26 [1; 31]36 [3; 14]38 [4; 16]88 [5; 11]
Chest pain0-27 [3; 17]15 [3; 10]36 [3; 10]
Cough512 [8; 17]419 [12; 29]510 [8; 14]1412 [10; 15]
Hepatomegaly728 [18; 42]723 [13; 40]2313 [10; 17]3716 [13; 20]
Splenomegaly735 [27; 45]1029 [22; 39]2321 [16; 27]4024 [20; 29]
Lymphadenectasis738 [25; 58]732 [22; 48]2716 [12; 21]4119 [15; 25]
Hepatitis848 [34; 67]1560 [52; 69]2438 [30; 49]4745 [38; 54]
Neurological48 [4; 17]38 [2; 36]144 [2; 9]215 [3; 10]
Cardiac319 [2; 100]25 [1; 19]129 [6; 14]179 [6; 16]
Hemophagocytic syndrome0-0-46 [2; 23]46 [2; 23]
Respiratory526 [12; 57]311 [6; 20]89 [4; 23]1613 [7; 21]
Orchitis/epididymitis167 [45; 100]76 [3; 12]349 [7; 12]429 [7; 12]
Osteoarthritis216 [8; 35]422 [9; 52]1123 [17; 31]1722 [17; 29]
Hepatitis (45% [95% CI 38%–54%]) and osteoarthritis (22% [95% CI 17%–29%]) were the most common complications. Central nervous system dysfunction (5% [95% CI 3%–10%]) which happened in overall patients included meningitis, encephalitis, cerebral infarction, and brain abscess. Cardiovascular diseases (9% [95% CI 6%–16%]) which were reported in overall patients involved the myocarditis, endocarditis, valvular neoplasm, valvular perforation, pericardial effusion, and heart failure. Hemophagocytic syndrome (6% [95% CI 2%–23%]) was only reported in adult patients. There were 13% of patients (95% CI: 7%–21%) suffering from respiratory manifestations, including cough, pneumonia, bronchial pneumonia, pleural effusion, respiratory failure, and pulmonary embolism. Orchitis or epididymitis occurred in 9% of the male patients (95% CI: 7%–12%).

3.4. Laboratory Tests

Table 4 shows the meta-analysis of the incidence of laboratory tests. There are 37 articles providing data of laboratory indicators of patients including 2999 cases. The mainly common reported abnormal laboratory tests were aleucocytosis (24.1% [95% CI 19.5%–29.8%]), anemia (23.9% [95% CI 18.5%–30.9%]), thrombocytopenia (15.8% [95% CI 12.7%–19.8%]), pancytopenia (13.2% [95% CI 9.3%–18.7%]), and leukocytosis (10.6% [95% CI 8.2%–13.7%]). The agglutination test was positive in 100% cases. Totally 30 articles including 4681 cases were tested by blood culture and Brucella melitensis species were isolated from (48.3% [95% CI 41.5%–56.3%]) cases.
Table 4

Meta-analysis of the incidence of laboratory tests.

LaboratoryThe number of articlesProportion [95% CI]
Thrombocytopenia320.158 [0.1268; 0.1979]
Aleucocytosis370.241 [0.1951; 0.2984]
Leukocytosis160.106 [0.0819; 0.1365]
Anemia280.239 [0.1847; 0.3094]
Pancytopenia60.132 [0.093; 0.187]

3.5. Misdiagnosis

There are 24 articles that provided information of misdiagnosis of patients including 2148 cases. 10 studies were from pastoral areas (3 from Xinjiang, 2 from Heilongjiang, 2 from Ningxia, 1 from Inner Mongolia, and 2 from Jilin) and 14 studies from nonpastoral areas (4 from Shandong, 3 from Beijing, 1 from Henan, 1 from Hebei, 1 from Hunan, 1 from Shanxi, 1 from Tianjin, 1 from Jiangxi, and 1 from Jiangsu). A total of 1287 (62.5% [95% CI 56.4%–69.2%]) patients were misdiagnosed at the first visit (Figure 3). The misdiagnosed cases mainly occurred in nonpastoral provinces. Most patients were easily misdiagnosed as cold, rheumatic fever, rheumatoid arthritis, typhoid fever and paratyphoid fever, tuberculosis, malaria, septicemia, and lumbar disc herniation at the first visit in Department of Rheumatology, Hematology, Orthopedics, or Respiration.
Figure 3

Forest plot of the incidence of misdiagnosis.

4. Discussion

Brucellosis is one of the most widespread zoonoses worldwide [82, 83]. The number of brucellosis patients is increasing year by year in China. Shi et al. [84] analyzed the incidence and spatial-temporal distribution of human brucellosis from 1955 to 2014 in China, and the report showed that human brucellosis had reemerged since the mid-1990s and the affected areas had expanded from northern pastureland provinces to southern coastal and southwestern areas since 2004. In China brucellosis has been increasingly causing huge economic loss, and it has been a population health problem in recent years. In humans, brucellosis involved multiorgans with a complicated and various clinical presentations ranging from nonspecific to severe symptoms [85], which makes brucellosis easily misdiagnosed as other diseases. If a chronic phase is developed for a lack of timely diagnosis and treatment, the disease can lead to a high rate of disability. Since the clinical summary of the relevant cases in China is published in Chinese, these cases are not included in the study using meta-analysis of Brucella abroad [86]. We analyzed the literature of clinical manifestations of human brucellosis in China. From our analyzed data, it shows that 57% selected studies from pastoral areas and 43% from nonpastoral and coastal areas, consistent with previous epidemiological findings that the disease affected areas have expanded from northern pastureland provinces to southern coastal and southwestern areas over the past decades in China, but brucellosis is still mainly popular in pastoral areas [87]. In this study, there are 79.4% of patients who had close contact with sick animals and 11.5% of cases had consumption of uncooked meat or dairy products, indicating that contacting with infected animals and consuming unsterile animal products are the main transmission routes in China. In the study, we found that the main clinical manifestations of human brucellosis are fever, fatigue, arthralgia, and muscle pain. The most common clinical syndromes of adult patients are fever, muscle pain, arthralgia, and sweating. Similar to our study, in a systematic review of the clinical manifestations of human brucellosis [86], the authors found that fever, arthralgia, myalgia, and back pain affected around half of the patients (78%, 65%, 47%, and 45%, resp.). There is controversy about whether clinical manifestations in children are significantly different from manifestations in adults. It had been reported in the literature that there was no significant difference in clinical manifestations between children and adults [88], which was very different in different literature. Some scholars reported that enlarged lymph nodes, spleen and liver, skin rashes, pharyngitis [89], and hematological and respiratory complications were more frequently observed in children than in adults [90]. Children had higher rates of hepatitis, osteoarticular manifestations [91], and lower rates of meningitis, endocarditis, spondylitis, and the progression to chronicity [92]. In the study, we found clinical differences between children and adults. Children had higher rates of rash, respiratory and cardiac complications, and orchitis/epididymitis. We also noted that chills, headache, and weight loss are less frequently observed in children patients. Multiorgan involvement of Brucella is probably underrecognised [93]. Bone, CNS, and epididymis are the most commonly included organs [6]. The results of the current study were similar to those in other reported articles [94]. In the current study, results show that hepatitis and osteoarthritis were the more frequent complications. Serious complications such as central nervous system dysfunction, cardiovascular diseases, respiratory manifestations, and hemophagocytic syndromes are also observed. Orchitis or epididymitis occurred in 9% of the male patients. Brucellosis complications remain a major medical problem and it must still be regarded as a serious health problem in China. In the study, results show that there is a high rate of misdiagnosis that mainly occurred in nonpastoral areas. Because of these manifestations such as fever, back pain, cough, gastrointestinal symptoms, and blood abnormalities, brucellosis is often misdiagnosed. Most misdiagnosed patients were admitted in Department of Rheumatology, Hematology, Orthopedics, and Respiration at the first visit. Brucella bacteria culture is the “gold standard” for the diagnosis of brucellosis [95, 96]. In the study, 87% of brucellosis patients have fever. However, we found that only 30 articles including 4681 cases were tested by blood culture and 48.3% of cases were positive of Brucella melitensis, indicating it may be the main reason of inappropriate diagnosis and inadequate therapy. Therefore, in order to reduce the rate of misdiagnosis effectively especially in the nonpastoral areas and provinces with high incidence of tuberculosis, it is necessary to broaden the ideas of clinical diagnosis with detailed history and carried out agglutination test and blood culture as early as possible for fever patients. One challenge in diagnosis of brucellosis is that the most common laboratory abnormalities are nonspecific. Most patients have normal blood cell counts on presentation. In the study, we found that the common abnormal laboratory tests were aleucocytosis (24.1%), anemia (23.9%), thrombocytopenia (15.8%), pancytopenia (13.2%), and leukocytosis (10.6%). In case of pancytopenia, the diagnosis of secondary hemophagocytosis should be considered. This condition may be triggered by Brucella and other intracellular pathogens [97, 98]. Our study has some limitations. First, although the incidence of brucellosis is very high in our country, the quantity and quality of articles reported in some provinces are not high, which leads to partial data omission. We failed to obtain more precise analysis of different clinical stages of brucellosis because part of the included literature did not clearly describe the brucellosis clinical stage and age classification. Second, most of the reported literatures lack detailed data on patient treatment options and prognosis, which results in the failure of analyzing therapeutic effect and prognosis. In summary, we found that brucellosis was mainly popular in pastoral areas, but the disease affected areas had expanded from northern pastureland provinces to southern coastal and southwestern areas in China. The infection is mostly associated with the contact with infected animals or through the consumption of raw animal products. Clinical symptoms include fever, fatigue, arthralgia, sweating, and muscle pain with complication such as osteoarthritis, hepatitis, central nervous system dysfunction, cardiovascular diseases, respiratory manifestations, orchitis or epididymitis, and hemophagocytic syndromes. Further research is needed to characterize the analysis for therapeutic effect and prognosis of brucellosis in China. Our study provides initial evidence for the accurate diagnosis.
  29 in total

Review 1.  Clinical presentations and diagnosis of brucellosis.

Authors:  Aysegul Ulu-Kilic; Gökhan Metan; Emine Alp
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-04

2.  Correlation between animal and human brucellosis in Italy during the period 1997-2002.

Authors:  F De Massis; A Di Girolamo; A Petrini; E Pizzigallo; A Giovannini
Journal:  Clin Microbiol Infect       Date:  2005-08       Impact factor: 8.067

3.  [Clinical analysis of 229 cases of brucellosis].

Authors:  Jia Liu; Cheng-tao Fu; Xiao-hong Chen
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2012-11

Review 4.  Haemophagocytic syndrome and rickettsial diseases.

Authors:  Antonio Cascio; Salvatore Giordano; Piera Dones; Silvia Venezia; Chiara Iaria; Ottavio Ziino
Journal:  J Med Microbiol       Date:  2010-12-16       Impact factor: 2.472

5.  [Analysis on the epidemiological features of human brucellosis in northern and southern areas of China, 2015-2016].

Authors:  Y J Shi; S J Lai; Q L Chen; D Mu; Y Li; X X Li; W W Yin; H J Yu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2017-04-10

Review 6.  Brucellosis: a re-emerging zoonosis.

Authors:  Mohamed N Seleem; Stephen M Boyle; Nammalwar Sriranganathan
Journal:  Vet Microbiol       Date:  2009-06-21       Impact factor: 3.293

7.  Brucellosis Outbreak in Children and Adults in Two Areas in Israel.

Authors:  Orli Megged; Bibiana Chazan; Atef Ganem; Abeer Ayoub; Anna Yanovskay; Waheeb Sakran; Dan Miron; Ahuva Dror-Cohen; Yoram Kennes; Svetlana Berdenstein; Daniel Glikman
Journal:  Am J Trop Med Hyg       Date:  2016-04-25       Impact factor: 2.345

8.  Isolation & characterization of Brucella melitensis isolated from patients suspected for human brucellosis in India.

Authors:  Anita Barua; Ashu Kumar; Duraipandian Thavaselvam; Smita Mangalgi; Archana Prakash; Sapana Tiwari; Sonia Arora; Kannusamy Sathyaseelan
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

9.  Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Authors:  Javier Ariza; Mile Bosilkovski; Antonio Cascio; Juan D Colmenero; Michael J Corbel; Matthew E Falagas; Ziad A Memish; Mohammad Reza Hasanjani Roushan; Ethan Rubinstein; Nikolaos V Sipsas; Javier Solera; Edward J Young; Georgios Pappas
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

10.  Epidemiological features and risk factors associated with the spatial and temporal distribution of human brucellosis in China.

Authors:  Yin-Jun Li; Xin-Lou Li; Song Liang; Li-Qun Fang; Wu-Chun Cao
Journal:  BMC Infect Dis       Date:  2013-11-16       Impact factor: 3.090

View more
  31 in total

Review 1.  Brucella Prosthetic Valve Endocarditis: A Systematic Review.

Authors:  Karima Taamallah; Fatma Hammami; Hédi Gharsallah; Makram Koubaa; Mounir Ben Jemaa; Wafa Fehri
Journal:  J Saudi Heart Assoc       Date:  2021-08-09

2.  Epidemiological Characteristics of Human Brucellosis - China, 2016-2019.

Authors:  Zhongfa Tao; Qiulan Chen; Yishan Chen; Yu Li; Di Mu; Huimin Yang; Wenwu Yin
Journal:  China CDC Wkly       Date:  2021-02-05

Review 3.  Sex and Gender Differences in Bacterial Infections.

Authors:  Sara P Dias; Matthijs C Brouwer; Diederik van de Beek
Journal:  Infect Immun       Date:  2022-09-19       Impact factor: 3.609

4.  Design of a multi-epitope vaccine candidate against Brucella melitensis.

Authors:  Min Li; Yuejie Zhu; Ce Niu; Xinru Xie; Gulishati Haimiti; Wenhong Guo; Mingkai Yu; Zhiqiang Chen; Jianbing Ding; Fengbo Zhang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

5.  Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise.

Authors:  Meibian Zhang; Weiming Yuan; Haijun Huang
Journal:  J Occup Health       Date:  2019-03-06       Impact factor: 2.708

6.  Whole-Genome Sequence of Brucella melitensis Strain B7, Isolated from a Blood Sample of a Brucellosis Patient from Hulunbuir, Inner Mongolia, China.

Authors:  Guoqing Zhang; Chen Liang; Chenfang Liu; Jing Zhang; Xiaoyu Pi; Yujia Zhang; Xiuwen Liang; Lijun Wang; Beiwen Zheng
Journal:  Microbiol Resour Announc       Date:  2019-06-13

7.  Predictive analysis of the number of human brucellosis cases in Xinjiang, China.

Authors:  Yanling Zheng; Liping Zhang; Chunxia Wang; Kai Wang; Gang Guo; Xueliang Zhang; Jing Wang
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

8.  Evaluating active versus passive sources of human brucellosis in Jining City, China.

Authors:  Xihong Sun; Wenguo Jiang; Yan Li; Xiuchun Li; Qingyi Zeng; Juan Du; Aitian Yin; Qing-Bin Lu
Journal:  PeerJ       Date:  2021-06-22       Impact factor: 2.984

9.  Improved Early Detection of Focal Brucellosis Complications with Anti-Brucella IgG.

Authors:  Nannan Xu; Xiaomeng Dong; Yongyuan Yao; Yanyan Guan; Fengzhe Chen; Feng Zheng; Gang Wang
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 11.677

10.  Epidemiological, Clinical and Laboratory Characteristics of Patients with Brucella Infection in Anhui Province, China.

Authors:  Cuixiao Shi; Lianzi Wang; Dongmei Lv; Gang Wang; Hylemariam Mihiretie Mengist; Tengchuan Jin; Bo Wang; Ying Huang; Yajuan Li; Yuanhong Xu
Journal:  Infect Drug Resist       Date:  2021-07-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.